BridgeBio Pharma Files Q1 2025 10-Q
Ticker: BBIO · Form: 10-Q · Filed: Apr 29, 2025 · CIK: 1743881
| Field | Detail |
|---|---|
| Company | Bridgebio Pharma, Inc. (BBIO) |
| Form Type | 10-Q |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
**BridgeBio Q1 2025 10-Q filed. All systems go.**
AI Summary
BridgeBio Pharma, Inc. filed its 10-Q for the period ending March 31, 2025. The company, incorporated in Delaware, operates in the Pharmaceutical Preparations sector. Key financial dates include a fiscal year end of December 31 and a filing date of April 29, 2025. The filing references various accounting standards and previous corporate structures, including BridgeBio Pharma LLC.
Why It Matters
This filing provides investors with an update on BridgeBio Pharma's financial health and operational status for the first quarter of 2025, crucial for understanding its ongoing performance and future prospects.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new disclosures.
Key Players & Entities
- BridgeBio Pharma, Inc. (company) — Filer
- 20250331 (date) — Period of Report
- 20250429 (date) — Filing Date
- 0001743881 (company) — Central Index Key
- 2834 (industry_code) — Standard Industrial Classification
- DE (state) — State of Incorporation
- 1231 (date) — Fiscal Year End
- 001-38959 (company) — SEC File Number
- Palo Alto, CA (location) — Business Address
- BridgeBio Pharma LLC (company) — Former Company Name
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the first quarter of 2025.
When was this 10-Q filed with the SEC?
The filing date was 20250429.
What is BridgeBio Pharma's Standard Industrial Classification code?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What was BridgeBio Pharma's former company name?
The former company name was BridgeBio Pharma LLC.
In which state was BridgeBio Pharma incorporated?
BridgeBio Pharma was incorporated in Delaware (DE).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 29, 2025 regarding BridgeBio Pharma, Inc. (BBIO).